PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
+25.21%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$13.9M
AUM Growth
+$13.9M
(-75%)
Cap. Flow
-$45.4M
Cap. Flow
% of AUM
-326.16%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
83
New
14
Increased
3
Reduced
23
Closed
37
Top Buys
| 1 |
Biogen
BIIB
|
$546K |
| 2 |
Elevance Health
ELV
|
$504K |
| 3 |
Humana
HUM
|
$494K |
| 4 |
Centene
CNC
|
$430K |
| 5 |
Pfizer
PFE
|
$294K |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
$2.23M |
| 2 |
Microchip Technology
MCHP
|
$2.23M |
| 3 |
Zimmer Biomet
ZBH
|
$2.09M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$2.03M |
| 5 |
Twilio
TWLO
|
$1.74M |
Sector Composition
| 1 | Healthcare | 91.76% |
| 2 | Communication Services | 0% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
| $1.07M | 7.65% |
17,795
-7,575
| -30% | -$453K |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $911K | 6.54% |
8,421
-13,715
| -62% | -$1.48M |
|
|
ALNA
3
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $776K | 5.57% |
284,285
| – | – |
|
4
Gilead Sciences
GILD
$140B
| $708K | 5.08% |
10,898
-17,604
| -62% | -$1.14M |
|
5
Penumbra
PEN
$10.5B
| $608K | 4.37% |
3,699
-8,859
| -71% | -$1.46M |
|
|
6
Zimmer Biomet
ZBH
$20.9B
| $552K | 3.96% |
3,689
-13,999
| -79% | -$2.09M |
|
|
7
Biogen
BIIB
$20.2B
| $546K | 3.92% |
+1,839
| New | +$546K |
|
|
NVRO
8
DELISTED
NEVRO CORP.
NVRO
| $531K | 3.81% |
4,515
-1,252
| -22% | -$147K |
|
|
9
Elevance Health
ELV
$72.4B
| $504K | 3.62% |
+1,669
| New | +$504K |
|
|
10
Humana
HUM
$36.9B
| $494K | 3.55% |
+1,347
| New | +$494K |
|
11
Cigna
CI
$80.3B
| $453K | 3.25% |
2,216
-4,916
| -69% | -$1M |
|
12
IQVIA
IQV
$31.4B
| $452K | 3.25% |
2,926
-5,641
| -66% | -$871K |
|
|
13
BioMarin Pharmaceuticals
BMRN
$11.3B
| $451K | 3.24% |
5,329
-24,012
| -82% | -$2.03M |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $436K | 3.13% |
18,035
+1,304
| +8% | +$31.5K |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $436K | 3.13% |
2,282
-5,092
| -69% | -$973K |
|
|
ARNA
16
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $431K | 3.09% |
9,484
-19,393
| -67% | -$881K |
|
|
17
Centene
CNC
$14.5B
| $430K | 3.09% |
+6,838
| New | +$430K |
|
18
Novartis
NVS
$244B
| $392K | 2.81% |
4,270
-6,441
| -60% | -$591K |
|
19
HCA Healthcare
HCA
$94.9B
| $345K | 2.48% |
2,335
-5,165
| -69% | -$763K |
|
|
20
Pfizer
PFE
$141B
| $294K | 2.11% |
+7,492
| New | +$294K |
|
21
ICU Medical
ICUI
$3.12B
| $258K | 1.85% |
+1,381
| New | +$258K |
|
|
DERM
22
DELISTED
Dermira, Inc.
DERM
| $256K | 1.84% |
16,892
-13,106
| -44% | -$199K |
|
23
Icon
ICLR
$13.8B
| $241K | 1.73% |
1,402
-1,810
| -56% | -$311K |
|
24
UnitedHealth
UNH
$281B
| $233K | 1.67% |
+791
| New | +$233K |
|
25
iRhythm Technologies
IRTC
$5.44B
| $231K | 1.66% |
3,389
-9,372
| -73% | -$639K |
|